[bracket] with the real Mason-Dixon topline, get counsel sign-off, then: (1) delete this banner, (2) change the robots meta to index, follow, (3) fill the two JSON-LD dates, (4) do the wiring in the publish checklist at the bottom of this file. Do not publish with any bracket still showing.
Press release · [Month Day], 2026
For immediate release
A survey of [N] U.S. adults, released days before an FDA advisory committee weighs a legal pathway for seven peptides, finds broad public support for a safe, prescription channel over the online grey market.
PONTE VEDRA BEACH, Fla. - A new national survey of [N] U.S. adults finds that [XX]% believe therapeutic peptides should be available through licensed pharmacies with a prescription, rather than the unregulated online "grey market" where most Americans obtain them today. The poll, conducted by Mason-Dixon Polling & Strategy and commissioned by the peptide-education resource Peppies, arrives just [N] days before the FDA's Pharmacy Compounding Advisory Committee meets July 23-24, 2026 to consider whether seven peptides should regain a lawful compounding pathway.
The survey also found:
The findings land against a documented safety backdrop. Peptide compounds placed in the FDA's "Category 2" in 2023 did not lose their audience - demand moved offshore, with U.S. imports of peptide and hormone compounds from China reaching roughly $328 million in the first three quarters of 2025, about double the year before.[1] Independent, peer-reviewed testing of falsified peptide products has found purity ranging from 5% to 75%, with arsenic and lead above the limits set for injectable drugs.[2] The FDA's own briefing documents for the July meeting state it "lacks sufficient information to know whether the drug would cause harm when administered to humans."[3]
To Underwood, the numbers point to a safety problem hiding in plain sight. "Millions of Americans are already injecting peptides - sourced from a sketchy Chinese company over WhatsApp or a TikTok profile's side hustle - and nobody is testing what's in the vial. Independent lab testing found these vials running as low as 5% of what's on the label, tainted with arsenic and lead - in some cases at ten times the toxic limit for an injectable drug, with the arsenic in its most poisonous form. Without a legal, tested pathway, this is peptide roulette - and millions of Americans are pulling the trigger," said Ken Underwood, founder of Peppies.
Peppies is transparent about where it stands and why. "We're not neutral, and we don't pretend to be," Underwood added. "We're building toward being a trusted peptides brand, and if a legal, regulated market emerges, we intend to take part in it. We'd benefit only from that legal market - never from the grey market we're warning people about. Our interest and the public's safety point the same direction, and we say so on our site and in the comment we filed with the FDA."
The committee's vote will be advisory and non-binding; any actual change to access would require separate FDA rulemaking, with its own formal public-comment period. At peppies.com, people can follow the process in plain English, read every claim linked to a primary source, and sign up to be notified when that official comment window opens. Peppies does not sell peptides and is not affiliated with the FDA.
Methodology. The survey was conducted by Mason-Dixon Polling & Strategy [dates], among [N] [registered voters / adults] nationwide, with a margin of error of ±[X.X] percentage points. It was commissioned and paid for by Peppies, LLC. Full topline results, crosstabs, and a downloadable summary are available at peppies.com/poll.html.
About Peppies. Peppies (peppies.com) is an independent, fully-cited consumer-education resource on therapeutic peptides and the U.S. regulatory process, building toward becoming America's first trusted peptides brand. It does not sell, promote, or facilitate the sale of any peptide, makes no claim that any peptide is safe or effective, and is not affiliated with the FDA. Peptides for Life.
Media contact: Ken Underwood · ken@@peppies.com